Jason Kim
President en MOLECULAR TEMPLATES, INC. .
Fortuna: 14 260 $ al 31/03/2024
Perfil
Jason S.
Kim's career history includes current and former positions as well as his education.
Currently, he holds the position of President, Chief Financial Officer & Treasurer at Molecular Templates, Inc. since 2023.
He is also the Chief Operating Officer at Molecular Templates OpCo, Inc. In the past, Mr. Kim worked as the Director of Business Development at ImClone LLC from 2003 to 2006.
He also served as the Director of Business & Corporate Development at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Additionally, he held positions as an Associate at Safeguard Scientifics, Inc. and Domain Associates LLC.
From 2010 to 2017, he was the President & Chief Financial Officer at Molecular Templates, Inc.
Mr. Kim completed his undergraduate studies at Wesleyan University.
He furthered his education by obtaining an MBA from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/01/2024 | 6 366 ( 0.12% ) | 14 260 $ | 31/03/2024 |
Cargos activos de Jason Kim
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | President | 01/02/2010 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Operating Officer | - |
Antiguos cargos conocidos de Jason Kim.
| Empresas | Cargo | Fin |
|---|---|---|
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Director of Finance/CFO | 01/08/2017 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 01/01/2009 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2006 |
| SAFEGUARD SCIENTIFICS, INC. | Corporate Officer/Principal | - |
Formación de Jason Kim.
| Wesleyan University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SAFEGUARD SCIENTIFICS, INC. | Finance |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Bolsa de valores
- Insiders
- Jason Kim
